Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in humans and
is a significant source of morbidity and mortality. Despite its prevalence, our mechanistic …

Atrial fibrillation (AF) is an arrhythmia that can occur as the result of numerous different
pathophysiological processes in the atria. Some aspects of the morphological and …

Background—Specific noninvasive signal processing was applied to identify drivers in
distinct categories of persistent atrial fibrillation (AF). Methods and Results—In 103 …

While management of atrial fibrillation (AF) patients is improved by guideline-conform
application of anticoagulant therapy, rate control, rhythm control, and therapy of …

For both the atria and ventricles, fibrosis is generally recognized as one of the key
determinants of conduction disturbances. By definition, fibrosis refers to an increased …

Over the last decade, mouse models have become a popular instrument for studying cardiac
arrhythmias. This review assesses in which respects a mouse heart is a miniature human …

Aims Atrial fibrillation (AF) produces a hypercoagulable state. Stimulation of protease-
activated receptors by coagulation factors provokes pro-fibrotic, pro-hypertrophic, and pro …

At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many
more suffer from undiagnosed, subclinical, or 'silent'AF. Atrial fibrillation-related …

The management of atrial fibrillation (AF) has seen marked changes in past years, with the
introduction of new oral anticoagulants, new antiarrhythmic drugs, and the emergence of …

Background—Endo-epicardial dissociation (EED) of electric activations resulting in
transmural conduction of fibrillation waves (breakthroughs) has been postulated to …